Clinical Trial Update: Phase II BGG492 Capsule Extension for Partial Epilepsy [Phase 2]

View source ↗

Summary

Phase II extension trial update for BGG492 capsule in partial epilepsy (partial onset seizures) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial Epilepsy
• Partial-onset Seizures

Drugs mentioned

• BGG492 capsule

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Partial Onset Seizures | Phase 2 | Status: COMPLETED